Anavex Life Sciences (AVXL) Could Be Worth Trading This Week

At the beginning of each trading week, most investors start making a list of stocks that are going to be worth tracking, and one of the stocks to watch this week could be the Anavex Life Sciences Corp (NASDAQ: AVXL).

The company, which is involved in developing treatments for conditions like Rett Syndrome, Parkinson’s disease, and Alzheimer’s disease among others, made a major announcement on March 31. The announcement was with regards to the Phase 2b/3 study of ANAVEX 2-73, which is an investigational compound meant for treating Alzheimer’s disease.

Related:  Why is Decision Diagnostics (DECN) Popping?

The company announced that the pre-planned review of the preliminary study data from Phase 2b/3 has been completed. It is a major milestone for Anavex and one that is likely going to be followed up on by many investors this week. In this sort of situation, it could be a good move for investors to start tracking the stock as well.

Anthony Gonzales

Biotech, Tech, and Crypto reporter Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.